Results 331 to 340 of about 5,954,376 (381)
Hormone Therapy and Biological Aging in Postmenopausal Women.
Liu Y, Li C.
europepmc +1 more source
Menopausal Hormone Therapy Use Among Postmenopausal Women.
Yang L, Toriola AT.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
JAMA, 2019
Hormone therapy is the most effective treatment for managing menopausal vasomotor symptoms. Hot flashes and night sweats affect approximately 70% of midlife women and may persist for a decade or longer.1 Bothersome vasomotor symptoms have a significant ...
J. Shifren, C. Crandall, J. Manson
semanticscholar +3 more sources
Hormone therapy is the most effective treatment for managing menopausal vasomotor symptoms. Hot flashes and night sweats affect approximately 70% of midlife women and may persist for a decade or longer.1 Bothersome vasomotor symptoms have a significant ...
J. Shifren, C. Crandall, J. Manson
semanticscholar +3 more sources
The 2022 hormone therapy position statement of The North American Menopause Society
Menopause, 2022“The 2022 Hormone Therapy Position Statement of The North American Menopause Society” (NAMS) updates “The 2017 Hormone Therapy Position Statement of The North American Menopause Society” and identifies future research needs.
M. M. M. N. F. Carolyn J. Crandall+12 more
semanticscholar +1 more source
Hormone therapy and phytoestrogens [PDF]
As ageing progresses the levels of sex hormones decrease in the human body. In the male population, the decrease or absence of testosterone leads to decreased strength and stamina, thin bones and a low sex drive (1). In the female population, the immediate symptoms of menopause include irregular periods, painful sexual intercourse due to vaginal ...
L. L. Lien, E. J. Lien
openaire +2 more sources
International Journal of Clinical Oncology, 2007
In spite of clinical practice guidelines such as the National Cancer Institute (NCI)-Physician Data Query (PDQ), in which primary androgen deprivation therapy (PADT) is not recommended at all as the primary treatment for localized prostate cancer, many such patients have actually been treated with PADT in Japan.
Yasuhide Kitagawa+6 more
openaire +3 more sources
In spite of clinical practice guidelines such as the National Cancer Institute (NCI)-Physician Data Query (PDQ), in which primary androgen deprivation therapy (PADT) is not recommended at all as the primary treatment for localized prostate cancer, many such patients have actually been treated with PADT in Japan.
Yasuhide Kitagawa+6 more
openaire +3 more sources